Medindia LOGIN REGISTER
Medindia
Advertisement

Gel may Help Slow Down Myopia Progression in Kids

by VR Sreeraman on August 28, 2008 at 2:43 PM
 Gel may Help Slow Down Myopia Progression in Kids

A new study from University of Oklahoma Department of Ophthalmology has found that daily use of medication called pirenzepine gel can slow down myopia progression in children, say researchers.

Myopia or nearsightedness is a condition in which focus on near objects is good, but distant objects appear blurry. Caused by a problem with the length of the eyeball or the curvature of the cornea, myopia gets worse over time in many children.

Advertisement

In the study led by Dr. R. Michael Stiatkowski of Dean McGee Eye Institute/University of Oklahoma Department of Ophthalmology, children with myopia were randomly assigned to treatment with pirenzepine gel or an inactive placebo gel. All children initially had "moderate" myopia, with an average refractive error of about -2.00 diopters.

Over a year of treatment, the team found that the average increase in myopia was significantly less for children using pirenzepine.

The new study presents the final results in 84 patients who continued treatment for a total of two years: 53 with pirenzepine and 31 with placebo.
Advertisement

Although myopia worsened in both groups of children, the rate of progression was slower with pirenzepine.

At the end of two years, myopia increased by an average of 0.58 diopters in children using pirenzepine compared to 0.99 diopters with placebo.

New glasses are generally prescribed when myopia worsens by at least 0.75 diopters. During the study, 37 percent of children using pirenzepine met 0.75 diopters cut-off compared with 68 percent of the placebo group.

Treatments to slow worsening myopia could also have important quality-of-life benefits.

Previous studies have suggested that a drug called atropine can delay progression of myopia. The new results show that pirenzepine-a related drug with fewer side effects-is also safe and effective for this purpose.

The study appears in the August issue of the Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).

Source: ANI
SRM
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
Anti-cancer Drug Navitoclax Help Treat Lower Back Pain
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Gel may Help Slow Down Myopia Progression in Kids Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests